109 related articles for article (PubMed ID: 38721214)
1. The Effectiveness of Pediatric Central Venous Access Device Surveillance and Rounding Team: A Single-Center Study.
Hanaki S; Katayama S; Nakada S
Cureus; 2024 Apr; 16(4):e57855. PubMed ID: 38721214
[TBL] [Abstract][Full Text] [Related]
2. Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.
van den Bosch CH; van der Bruggen JT; Frakking FNJ; Terwisscha van Scheltinga CEJ; van de Ven CP; van Grotel M; Wellens LM; Loeffen YGT; Fiocco M; Wijnen MHWA
J Pediatr Surg; 2019 Sep; 54(9):1894-1900. PubMed ID: 30415957
[TBL] [Abstract][Full Text] [Related]
3. Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.
Ornowska M; Wong H; Ouyang Y; Mitra A; White A; Willems S; Wittmann J; Reynolds S
Trials; 2022 Aug; 23(1):719. PubMed ID: 36042488
[TBL] [Abstract][Full Text] [Related]
4. Pediatric central venous access devices: practice, performance, and costs.
Ullman AJ; Gibson V; Takashima MD; Kleidon TM; Schults J; Saiyed M; Cattanach P; Paterson R; Cooke M; Rickard CM; Byrnes J; Chopra V
Pediatr Res; 2022 Nov; 92(5):1381-1390. PubMed ID: 35136199
[TBL] [Abstract][Full Text] [Related]
5. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
[TBL] [Abstract][Full Text] [Related]
6. Central venous access device-related infections in patients with haemophilia.
Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
[TBL] [Abstract][Full Text] [Related]
7. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
[TBL] [Abstract][Full Text] [Related]
8. Road map for improvement: Point prevalence audit and survey of central venous access devices in paediatric acute care.
Ullman AJ; Cooke M; Kleidon T; Rickard CM
J Paediatr Child Health; 2017 Feb; 53(2):123-130. PubMed ID: 27709723
[TBL] [Abstract][Full Text] [Related]
9. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial.
Ullman AJ; Kleidon T; Gibson V; McBride CA; Mihala G; Cooke M; Rickard CM
BMC Cancer; 2017 Aug; 17(1):595. PubMed ID: 28854967
[TBL] [Abstract][Full Text] [Related]
10. Central venous Access device SeCurement And Dressing Effectiveness (CASCADE) in paediatrics: protocol for pilot randomised controlled trials.
Ullman AJ; Kleidon T; Gibson V; Long DA; Williams T; McBride CA; Hallahan A; Mihala G; Cooke M; Rickard CM
BMJ Open; 2016 Jun; 6(6):e011197. PubMed ID: 27259529
[TBL] [Abstract][Full Text] [Related]
11. Central Venous Access Devices (CVAD) in Pediatric Oncology Patients-A Single-Center Retrospective Study Over More Than 9 Years.
Beck O; Muensterer O; Hofmann S; Rossmann H; Poplawski A; Faber J; Gödeke J
Front Pediatr; 2019; 7():260. PubMed ID: 31294007
[No Abstract] [Full Text] [Related]
12. Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care.
Mitchell ML; Ullman AJ; Takashima M; Davis C; Mihala G; Powell M; Gibson V; Zhang L; Bauer M; Geoffrey Playford E; Rickard CM
Aust Crit Care; 2020 Sep; 33(5):441-451. PubMed ID: 31757717
[TBL] [Abstract][Full Text] [Related]
13. Surveillance methods for central venous access device-associated infections in Canadian pediatric hospitals.
Langley JM; LaRoche L; Hanakowski M
Can J Infect Control; 1995; 10(3):80-2. PubMed ID: 8555515
[TBL] [Abstract][Full Text] [Related]
14. Outcomes, cost comparison, and patient satisfaction during long-term central venous access in cancer patients: Experience from a Tertiary Care Cancer Institute in South India.
Babu KG; Suresh Babu MC; Lokanatha D; Bhat GR
Indian J Med Paediatr Oncol; 2016; 37(4):232-238. PubMed ID: 28144088
[TBL] [Abstract][Full Text] [Related]
15. Central Venous Access Device Complications in Patients Receiving Parenteral Nutrition in General Ward Settings: A Retrospective Analysis.
Martincich I; Cini K; Lapkin S; Lord H; Fernandez R
JPEN J Parenter Enteral Nutr; 2020 Aug; 44(6):1104-1111. PubMed ID: 31785017
[TBL] [Abstract][Full Text] [Related]
16. Routine Catheter Lock Solutions in Pediatric Cancer Care: A Pilot Randomized Controlled Trial of Heparin vs Saline.
Ullman AJ; Edwards R; Walker R; Roy J; Paton A; Rickard CM; Cooke M; Bradford N; Gibson V; Cattanach P; Paterson RS; Takashima M; Byrnes J; Keogh S; Kleidon T
Cancer Nurs; 2022 Nov-Dec 01; 45(6):438-446. PubMed ID: 35131974
[TBL] [Abstract][Full Text] [Related]
17. Repair of central venous access devices in intestinal failure patients is safe and cost-effective: A retrospective single centre cohort study.
Fletcher J; Woodham D; Cooper SC
Clin Nutr; 2021 Jun; 40(6):4263-4266. PubMed ID: 33551216
[TBL] [Abstract][Full Text] [Related]
18. Catheter-associated bloodstream infections in adults with cancer: a prospective randomized controlled trial.
Mollee P; Okano S; Abro E; Looke D; Kennedy G; Harper J; Clouston J; Van Kuilenburg R; Geary A; Joubert W; Eastgate M; Jones M
J Hosp Infect; 2020 Oct; 106(2):335-342. PubMed ID: 32712388
[TBL] [Abstract][Full Text] [Related]
19. Experiences of children with central venous access devices: a mixed-methods study.
Ullman AJ; Kleidon TM; Gibson V; Takashima M; Schults J; Cattanach P; Paterson R; Cooke M; Byrnes J; Saiyed M; Chopra V; Rickard C
Pediatr Res; 2023 Jan; 93(1):160-167. PubMed ID: 35411069
[TBL] [Abstract][Full Text] [Related]
20. Skin Complications Associated With Pediatric Central Venous Access Devices: Prevalence, Incidence, and Risk.
Ullman AJ; Kleidon TM; Turner K; Gibson V; Dean A; Cattanach P; Pitt C; Woosley J; Marsh N; Gavin N; Takashima M; Rickard CM
J Pediatr Oncol Nurs; 2019; 36(5):343-351. PubMed ID: 31104548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]